Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
about
Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in miceThe mucosal immune system: From dentistry to vaccine developmentNew approaches to understanding the immune response to vaccination and infectionAttenuated vesicular stomatitis viruses as vaccine vectorsBiodegradable polymeric microsphere-based vaccines and their applications in infectious diseasesDevelopment of stable influenza vaccine powder formulations: challenges and possibilitiesTrivalent intranasal influenza vaccine, live.Antigen trafficking and accessory cell function in respiratory epithelial cells.Influence of prior influenza vaccination on antibody and B-cell responses.Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptideIntranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humansMucosal immunity and tolerance: relevance to vaccine development.Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challengeInduction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell lineA controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responsesSafety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.Orally administered Giardia duodenalis extracts enhance an antigen-specific antibody response.Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection.Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults.Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.Systems biology of vaccination for seasonal influenza in humans.Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The NetherlandsSalivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunizationComparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.Swine as a model for influenza A virus infection and immunity.The lung may play a role in the pathogenesis of rheumatoid arthritis.Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose.Immune Defense in Upper Airways: A Single-Cell Study of Pathogen-Specific Plasmablasts and Their Migratory Potentials in Acute Sinusitis and Tonsillitis.Localized mucosal response to intranasal live attenuated influenza vaccine in adultsLive vaccines for human metapneumovirus designed by reverse genetics.Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids
P2860
Q24548847-92747595-FF21-4A04-90A2-893EEF55FCECQ26783887-91B8EAE4-B3AF-4627-8C58-D42DBCEDB089Q26800283-E83FBBB1-6C0F-482A-982F-15C7C267B507Q27469358-27440263-F141-4E2F-8CF7-32618390C827Q28087409-27042D82-ABF2-41AC-B00D-C6BF01750108Q30368221-E1778248-214A-4842-A845-2212DCD3C647Q30434868-F04A4752-A399-43DD-8B1A-82F6DE491634Q30759145-F90B970A-FE9F-4BF0-8C2E-1E9E056677C3Q33361605-2AE0D1AA-E492-41C5-9545-168FCA47C904Q33675745-D71C4408-2FA2-45D1-9B12-88B6E71F3994Q33752052-62A649BC-5442-4B76-BB45-AAC4FF8A5AD2Q33756767-2980A5E4-335D-46AC-9A86-5B35FDA8793EQ33776172-4D9FAD38-DD2A-4654-A13B-E8DE5F1BE571Q33783986-BE7DF6C2-269C-417B-A96E-1C8B787147B5Q33784161-90EA8166-66B4-4916-BB76-CCAE06E487B2Q33788861-3AC28FDB-1F70-4EE6-AC8C-85BC1AF877ECQ33858496-3BF46259-3483-4109-B922-E088A8C6E218Q34000204-115BD397-41A8-4D65-BF19-4DA89DADC885Q34008338-63E05991-B291-430C-A1A7-A7E7EEC71378Q34009465-7B2B8E60-90CD-48FB-8B22-E9604FFB19C1Q34068059-4AA75C52-0F43-4351-86A8-94B38388023DQ34309830-AB374171-8C3C-48A6-9EA5-336A6237113CQ34621661-075BA306-97A2-4665-9356-AC3E2F5ABA38Q35005641-C28E6248-DAFD-4FAC-A9C1-AF37DF9EA9B4Q35022776-5AEAD74D-EFBF-4525-A058-25DB21BDBE97Q35093052-BCE94E6D-4B1B-43D7-81CD-5A0280B6FCBFQ35118722-ADAC0117-AE6A-4634-8332-C09D46163395Q35230589-774E2A17-91E0-4D1D-AFDA-B63A52BB9A04Q35482140-1616788A-D5E3-45E2-B96D-1EB0A6385FD5Q35533881-F9E31948-E8EE-4EF0-8B64-FF3615EBAEA0Q35545581-A240A6B5-3FC3-49A2-8276-E44912C7D152Q35550710-5D3741A0-6514-42B6-A65B-6727AB417D08Q35634295-D487F4BA-2E18-4C1B-B4F7-242952087C87Q35635820-6601D277-38F5-4924-AF26-20D791CE0B00Q35747705-433D7C5E-9A72-4787-8DB1-A60CDAA29FF9Q35798811-F2A099C4-82FF-41BB-A86F-A24F7B440D27Q36002991-EF85987F-341D-4D6F-B83F-7FA54304226CQ36606611-01FA76C4-DB25-4B2F-B475-DD5CBA264577Q36689031-5AF65B59-2581-4D63-B171-3C50CFDC8534Q36750553-9B852EF2-6F01-4C49-9E4E-CA030893D28D
P2860
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Human immune responses to infl ...... by systemic or mucosal routes.
@en
Human immune responses to infl ...... by systemic or mucosal routes.
@nl
type
label
Human immune responses to infl ...... by systemic or mucosal routes.
@en
Human immune responses to infl ...... by systemic or mucosal routes.
@nl
prefLabel
Human immune responses to infl ...... by systemic or mucosal routes.
@en
Human immune responses to infl ...... by systemic or mucosal routes.
@nl
P2093
P1433
P1476
Human immune responses to infl ...... by systemic or mucosal routes.
@en
P2093
Clements ML
Mestecky J
Moldoveanu Z
P304
P356
10.1016/0264-410X(95)00016-T
P407
P577
1995-08-01T00:00:00Z